Mouse Anti-VAMP1 Recombinant Antibody (SP10) (CBMAB-S6582-CQ)
Compare
Online Inquiry
Basic Information
Formulations & Storage [For reference only, actual COA shall prevail!]
Target
Biological Process vesicle fusion Source:GO_Central1 Publication
Cytoplasmic vesicle, secretory vesicle, synaptic vesicle membrane
Synapse, synaptosome
Isoform 2
Cytoplasmic vesicle membrane
Synapse, synaptosome
Isoform 3
Mitochondrion outer membrane
An autosomal dominant form of spastic ataxia, a progressive neurodegenerative disorder characterized by lower-limb spasticity and generalized ataxia with dysarthria, impaired ocular movements, and gait disturbance.
Myasthenic syndrome, congenital, 25, presynaptic (CMS25):
A form of congenital myasthenic syndrome, a group of disorders characterized by failure of neuromuscular transmission, including pre-synaptic, synaptic, and post-synaptic disorders that are not of autoimmune origin. Clinical features include easy fatigability and muscle weakness. CMS25 is an autosomal recessive form characterized by hypotonia and generalized muscle weakness apparent from birth. Affected individuals have feeding difficulties and delayed motor development, usually never achieving independent ambulation. Additional variable features include eye movement abnormalities, joint contractures, and rigid spine.
Helical: 97-116
Vesicular: 117-118
(Microbial infection) Targeted and hydrolyzed by C.botulinum neurotoxin type D (BoNT/D, botD) which probably hydrolyzes the 61-Arg-|-Leu-62 bond and inhibits neurotransmitter release (PubMed:22289120).
BoNT/D has low catalytic activity on this protein due to its sequence (PubMed:22289120).
Note that humans are not known to be infected by C.botulinum type D.
(Microbial infection) Targeted and hydrolyzed by C.botulinum neurotoxin type F (BoNT/F, botF) which probably hydrolyzes the 60-Gln-|-Lys-61 bond and inhibits neurotransmitter release (PubMed:22289120).
(Microbial infection) Targeted and hydrolyzed by C.botulinum neurotoxin type X (BoNT/X) which probably hydrolyzes the 68-Arg-|-Ala-69 bond and inhibits neurotransmitter release (PubMed:29540745).
It remains unknown whether BoNT/X is ever produced, or what organisms it targets.
Submit a review and get a Coupon or an Amazon gift card. 20% off Coupon
$30 eGift Card
Submit a review
Loading...
Please try the standard protocols which include: protocols, troubleshooting and guide.
Enzyme-linked Immunosorbent Assay (ELISA)
Flow Cytometry
Immunofluorescence (IF)
Immunohistochemistry (IHC)
Immunoprecipitation (IP)
Western Blot (WB)
Enzyme-Linked Immunospot (ELISpot)
Proteogenomics
Other Protocols
Related Products
Mouse Anti-VAMP1 Recombinant Antibody (Syn-58) (CAT#: CBMAB-AO1058LY)
Mouse Anti-VAMP1 Recombinant Antibody (SP11) (CAT#: CBMAB-S6583-CQ)
Rabbit Anti-VAMP1 Recombinant Antibody (BA0330) (CAT#: CBMAB-0936CQ)
Mouse Anti-VAMP1 Recombinant Antibody (SP-11) (CAT#: CBMAB-0935CQ)
Mouse Anti-VAMP1 Recombinant Antibody (CBXS-0940) (CAT#: CBMAB-S3854-CQ)
Mouse Anti-VAMP1 Recombinant Antibody (CBXS-0941) (CAT#: CBMAB-S3855-CQ)
Mouse Anti-VAMP1 Recombinant Antibody (CBXS-5688) (CAT#: CBMAB-S0558-CQ)
Mouse Anti-VAMP1 Recombinant Antibody (5A4) (CAT#: CBMAB-A9849-LY)
Mouse Anti-VAMP1 Recombinant Antibody (5F3) (CAT#: CBMAB-A9850-LY)
Custom Antibody Labeling
We also offer labeled antibodies developed using our catalog antibody products and nonfluorescent conjugates (HRP, AP, Biotin, etc.) or fluorescent conjugates (Alexa Fluor, FITC, TRITC, Rhodamine, Texas Red, R-PE, APC, Qdot Probes, Pacific Dyes, etc.).
Online InquiryContact us
